Epstein Secrets

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

Accrued Int Paid BRASKEM FINANCE LTD 144A 7 3/8% OCT 29 2049 DTD 10/04/2010 HELD BY EUROCLEAR ISIN US10553YAC93 SEDOL B3WJX06 (ID: 10553Y-9A-5) BANC OF AMERICA FUNDING CORPORATION SER 2006-G CL 2A5 FLOATING RATE JUL 20 2036 DTD 07/31/2006 @ 65.00 JP MORGAN SECURITIES LLC (BIDL) TRADE DATE 04/12/12 FACE VALUE 6,000,000.00 (ID: 0

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP

JP MORGAN SECURITIES LLC (BIDL) TRADE DATE 08/15/12 FACE VALUE 10,000,000.00 (ID: 073879-LR-7) 8/20 8/21 Corporate Interest Accrued Int Paid BANC OF AMERICA FUNDING CORPORATION SER 2006-G CL 2A5 FLOATING RATE JUL 20 2036 DTD 07/31/2006 (ID: 05950M-AF-7) TO REVERSE ENTRY OF 08/16/2012 MASTR ALTERNATIVE LOANS TRUST 2003-4 CL B

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973

37045V-20-9) CIT GROUP INC 144A 7% MAY 02 2017 DTD 06/15/2011 (ID: 125581-GA-0) CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 (ID: 125581-FZ-6) BANC OF AMERICA FUNDING CORPORATION SER 2006-G CL 2A5 FLOATING RATE JUL 20 2036 DTD 07/31/2006 (ID: 05950M-AF-7) Misc Disbursement TRANSFERRED BY WIRE TO MORT INC. AS REQUESTED MORTGAGE

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

144A 7% MAY 02 2017 DTD 06/15/2011 AS OF 06/11/12 (ID: 125581-GA-0) BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% @ 0.507812 PER SHARE (ID: 06739H-36-2) BANC OF AMERICA FUNDING CORPORATION SER 2006-G CL 2A5 FLOATING RATE JUL 20 2036 DTD 07/31/2006 (ID: 05950M-AF-7) SEQUOIA MORTGAGE TRUST SER 2003-1 CL B1 FLOATING RATE APR 20 2033 DTD 02

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

INC 7 5/8% JAN 15 2018 DTD 07/15/2011 (ID: 629377-BN-1) JP MORGAN CHASE BANK NA 6.200% 04/16/2015 DTD 04/16/2012 AS OF 07/16/12 (ID: 4662A0-4Q-1) BANC OF AMERICA FUNDING CORPORATION SER 2006-G CL 2A5 FLOATING RATE JUL 20 2036 DTD 07/31/2006 (ID: 05950M-AF-7) SEQUOIA MORTGAGE TRUST SER 2003-1 CL B1 FLOATING RATE APR 20 2033 DTD 02